Trexquant Investment’s Sutro Biopharma STRO Stock Holding History

Trexquant Investment’s Portfolio STRO Stock Details STRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$855K	Buy	+34,343	New	+$621K	0.01%	1282
2023 Q4	–	Sell	-2,042	Closed	-$70.9K	–	1767
2023 Q3	$70.9K	Sell	2,042 -8,213	-80%	-$358K	﹤0.01%	1406
2023 Q2	$477K	Sell	10,255 -8,031	-44%	-$400K	0.01%	1024
2023 Q1	$845K	Buy	18,286 +2,865	+19%	+$182K	0.02%	801
2022 Q4	$1.25M	Buy	15,421 +9,634	+166%	+$670K	0.04%	566
2022 Q3	$321K	Buy	+5,787	New	+$343K	0.01%	998
2022 Q1	–	Sell	-1,404	Closed	-$209K	–	1712
2021 Q4	$209K	Buy	+1,404	New	+$252K	0.01%	1125
2020 Q3	–	Sell	-3,260	Closed	-$253K	–	1519
2020 Q2	$253K	Buy	+3,260	New	+$313K	0.02%	963
2020 Q1	–	Sell	-1,022	Closed	-$112K	–	1402
2019 Q4	$112K	Buy	+1,022	New	+$105K	0.01%	974

Other funds holding STRO

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Trexquant Investment's STRO Position: Q1 2026 in Review

Trexquant Investment opened a new position in Sutro Biopharma (STRO) in Q1 2026: 34,343 shares worth $855K. The stake represents 0.01% of the portfolio and ranks #1282 among its holdings. This is a return to the name: Trexquant Investment previously reported a position in STRO as recently as Q3 2023.

Trexquant Investment first reported a position in STRO in Q4 2019 and has held it in 9 quarters since. The position peaked at $1.25M in Q4 2022. 78 funds tracked by Wall St. Rank hold STRO as of Q1 2026.

Trexquant Investment held 34,343 shares of Sutro Biopharma worth $855K as of Q1 2026.
Sutro Biopharma was a new Trexquant Investment position in Q1 2026.
Sutro Biopharma made up 0.01% of Trexquant Investment's portfolio in Q1 2026, its #1282 holding.
Trexquant Investment first reported a position in Sutro Biopharma in Q4 2019 and has held it in 9 quarters since.
Trexquant Investment's Sutro Biopharma position peaked at $1.25M in Q4 2022.
78 funds tracked by Wall St. Rank held Sutro Biopharma as of Q1 2026.

Based on Trexquant Investment's 13F filing for Q1 2026, filed 15 May 2026.